Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRegional Reit Regulatory News (RGL)

Share Price Information for Regional Reit (RGL)

Share Price is delayed by 15 minutes
Get Live Data
90.40    2.00 (2.26%)
Bid:
88.10
Ask:
93.00
Spread: 4.90 (5.562%)
Market Cap: £146.53m
RGL Live PriceLast checked at - London Stock Exchange

Intraday Regional Reit Share Chart

Response to Press Speculation

12 Mar 2024 07:00

RNS Number : 4256G
Regional REIT Limited
12 March 2024
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN ARE FOR INFORMATION PURPOSES ONLY AND DO NOT CONSTITUTE AN OFFER OF SECURITIES IN ANY JURISDICTION.

This announcement contains certain inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

12 March 2024

REGIONAL REIT LIMITED

("Regional REIT" or the "Company", together with its subsidiaries the "Group")

Response to press speculation

Further to the Q4 trading update published on 2 February 2024 and the dividend declaration announcement on 22 February 2024 (together, the "Previous Announcements"), Regional REIT (LSE: RGL) notes the recent press speculation regarding the possibility of the Company undertaking an equity capital raise of around £75 million.

As indicated in the Previous Announcements, the Company is actively exploring a range of refinancing options, including debt and/or equity, in respect of the existing £50 million retail bond (the "Retail Bond") given its maturity date in August 2024.  

The Company confirms that significant preparatory work has been undertaken to date in respect of both the debt and equity options, which remain under active consideration.

In the event that the Company proceeds with an equity issue, the Company expects that it would be at a material discount to the Company's current share price and would be subject to, amongst other things, shareholder approval.

The Company continues to consider its options and a further announcement will be made when appropriate.

- ENDS -

 

Enquiries:

 

Regional REIT Limited

 

Press enquiries through Buchanan

ARA Europe Private Markets Limited

Tel: +44 (0) 20 7845 6100

Investment Adviser to the Group

Adam Dickinson, Investor Relations

London & Scottish Property Investment Management 

Tel: +44 (0) 141 248 4155

Asset Manager to the Group

Stephen Inglis

Buchanan Communications

Tel: +44 (0) 20 7466 5000

Financial PR

Charles Ryland, Henry Wilson, George Beale

 

About Regional REIT

Regional REIT Limited ("Regional REIT" or the "Company") and its subsidiaries (the "Group") is a United Kingdom ("UK") based real estate investment trust that launched in November 2015. It is managed by London & Scottish Property Investment Management Limited, the Asset Manager, and ARA Europe Private Markets Limited, the Investment Adviser.

Regional REIT's commercial property portfolio is comprised wholly of income producing UK assets and, predominantly, of offices located in the regional centres outside of the M25 motorway. The portfolio is geographically diversified, with 144 properties and 978 occupiers as at 31 December 2023, with a valuation of c.£700.7m.

Regional REIT pursues its investment objective by investing in, actively managing and disposing of regional core and core plus property assets. It aims to deliver an attractive total return to its Shareholders, targeting greater than 10% per annum, with a strong focus on income supported by additional capital growth prospects.

The Company's shares were admitted to the Official List of the UK's Financial Conduct Authority and to trading on the London Stock Exchange on 6 November 2015. For more information, please visit the Group's website at www.regionalreit.com .

Cautionary Statement

This announcement has been prepared solely to provide additional information to Shareholders to assess the Group's performance in relation to its operations and growth potential. The announcement should not be relied upon by any other party or for any other reason. Any forward looking statements made in this announcement are done so by the Directors in good faith based on the information available to them up to the time of their approval of this document. However, such statements should be treated with caution due to the inherent uncertainties, including both economic and business risk factors, underlying any such forward-looking information.

ESMA Legal Entity Identifier ("LEI"): 549300D8G4NKLRIKBX73

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SPCDGGDXSXBDGSB
Date   Source Headline
19th May 20264:48 pmRNSResult of AGM
19th May 20267:00 amRNSQ1 2026 Trading Update & Dividend Declaration
1st Apr 20267:00 amRNSNotice of AGM
24th Mar 20267:00 amRNSAnnual Financial Report 2025 Full Year Results
20th Mar 202610:10 amRNS-RInvestor Presentation
19th Feb 20267:00 amRNSQ4 2025 Dividend, 2025 Valuation, Trading Update
24th Dec 20257:00 amRNSBanking Facility Refinanced
11th Dec 20257:00 amRNSSimplified Management Arrangements
10th Dec 20257:00 amRNSDisposals Programme Update
27th Nov 20252:02 pmRNSDirector/PDMR Shareholding
25th Nov 202511:07 amRNSDirector/PDMR Shareholding
24th Nov 202510:01 amRNSDirector Declaration
12th Nov 20257:01 amRNSQ3 2025 Trading Update and Dividend Declaration
24th Sep 202512:30 pmRNS-RInvestor Presentation via Investor Meet Company
18th Sep 20257:00 amRNSDisposal of Clearblue Innovation Centre for £8.8m
11th Sep 20253:49 pmRNSDirector/PDMR Shareholding
9th Sep 20257:00 amRNS2025 Half Year Results and Dividend Declaration
21st Jul 20259:45 amRNSDirectorate Change
10th Jul 20251:29 pmRNSHolding(s) in Company
7th Jul 20255:02 pmRNSDirector/PDMR Shareholding
26th Jun 20257:00 amRNSLettings Update
15th May 20252:50 pmRNSResult of AGM
15th May 20257:00 amRNSQ1 2025 Trading Update & Dividend Declaration
1st Apr 20257:00 amRNSNotice of AGM
31st Mar 20255:33 pmRNSHolding(s) in Company (Correction)
25th Mar 20257:00 amRNS2024 Full Year Results
26th Feb 20257:00 amRNSAppointment of Joint Broker
20th Feb 20257:00 amRNSQ4 Dividend, Year End Valuation and Trading Update
20th Jan 20257:00 amRNS-RAnnual Tenant Survey Published
18th Dec 20247:00 amRNSAppointment of Independent NED & Chair Designate
12th Dec 20247:00 amRNSBorrowings Further Reduced
13th Nov 20247:00 amRNSQ3 2024 Trading Update and Dividend Declaration
28th Oct 20247:00 amRNSSolar Panel JV with Sunbird Solar
21st Oct 20244:00 pmRNSDirector Appointment
16th Oct 20244:42 pmRNSHolding(s) in Company
11th Oct 20247:00 amRNSDirectorate Changes
10th Sep 20247:00 amRNS2024 Half Year Results
30th Aug 20247:00 amRNSChange of AIFM
8th Aug 20247:00 amRNSRepayment of Retail Bond
5th Aug 20242:31 pmRNSResult of AGM
5th Aug 20247:00 amRNSAGM Trading Update
1st Aug 202410:11 amRNSTotal Voting Rights
29th Jul 202411:19 amRNSCompletion of Share Consolidation
25th Jul 202411:52 amRNSHolding(s) in Company
24th Jul 20245:59 pmRNSHolding(s) in Company
23rd Jul 20245:17 pmRNSDirector/PDMR Shareholding
23rd Jul 20241:31 pmRNSDirector/PDMR Shareholding
23rd Jul 20241:29 pmRNSDirector/PDMR Shareholding
22nd Jul 20245:11 pmRNSDirector/PDMR Shareholding
22nd Jul 20245:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.